BBIO
BridgeBio Pharma, Inc.Company with tickers: BBIO
CIK
1743881
CUSIP
10806X102
Shares Outstanding
195,861,242
13F Activity (30d)
231 filings
225 filers
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization. Amounts come exclusively from tagged SEC data, so periods a company never tagged show no figure.
Program Authorized
$500,000,000
as of 2026-05-06
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2026-03-31 YTD | $82,500,000 | 10-Q, filed 2026-05-07 |
| 2025-12-31 | $48,276,000 | 10-K, filed 2026-02-24 |
| 2024-12-31 | $0 | 10-K, filed 2026-02-24 |
| 2023-12-31 | $0 | 10-K, filed 2026-02-24 |
| 2022-12-31 | $0 | 10-K, filed 2024-02-22 |
| 2021-12-31 | $200,000,000 | 10-K, filed 2024-02-22 |
| 2020-12-31 | $75,000,000 | 10-K, filed 2023-02-23 |
Recent quarters
| Quarter Ended | Cash Spent | Source |
|---|---|---|
| 2026-03-31 | $82,500,000 | 10-Q, filed 2026-05-07 |
| 2025-12-31 | $0 Δ | 10-K, filed 2026-02-24 |
| 2025-09-30 | $0 Δ | 10-Q, filed 2025-10-29 |
| 2025-06-30 | $0 Δ | 10-Q, filed 2025-08-05 |
| 2025-03-31 | $48,276,000 | 10-Q, filed 2026-05-07 |
| 2024-12-31 | $0 Δ | 10-K, filed 2026-02-24 |
| 2024-09-30 | $0 Δ | 10-Q, filed 2025-10-29 |
| 2024-06-30 | $0 Δ | 10-Q, filed 2025-08-05 |
| 2024-03-31 | $0 | 10-Q, filed 2025-04-29 |
| 2021-12-31 | $1,542,000 Δ | 10-K, filed 2024-02-22 |
| 2021-09-30 | $143,150,000 Δ | 10-Q, filed 2022-11-03 |
| 2021-06-30 | $5,308,000 Δ | 10-Q, filed 2022-08-04 |